Jacobio Pharmaceuticals Group Co., Ltd. (01167)
Jacobio Pharmaceuticals Group Co., Ltd., an investment holding company, engages in the in-house discovery and development of oncology therapies. Its clinical stage candidates include Glecirasib (JAB-21822), a KRAS G12C inhibitor under multiple stage studies for indications such as NSCLC, PDAC, CRC, and other solid tumors; Sitneprotafib (JAB-3312), an SHP2 inhibitor that is in Phase III trials for NSCLC indication; JAB-23E73
Office
CS Hotline: +852 3018 4526
Trading days: 24 hours
Non-trading days: 9:00-18:00
Email: cs@usmarthk.com
Address: 26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong
WhatsApp: +852 5989 2641
Physical Store（set to open in Q2 2025）
Lok Ma Chau Store
West Kowloon Store
Address：
Shop LMC 307, 3/F, Lok Ma Chau MTR Station, Lok Ma Chau
Opening Hour:
9am - 9pm (Mon - Sat)
10am - 6pm (Sun and Public Holiday)
（set to open in Q2 2025）
